Realmind: A Prospective and Retrospective Study to Characterize Real-World Use of Tafasitamab Plus Lenalidomide in US Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphom... von Brem, Elizabeth A., Burke, John M., Vukcevic, Mirko, Kloepfer, Pia, Saverno, Kimberly, Abdulhaq, Haifaa, Evens, Andrew M, Porcu, Pierluigi, Shadman, Mazyar, Flowers, Christopher R.

Volltext

Body Mass Index and Survival in a Prospective Randomized Trial of Localized High-Risk Renal Cell Carcinoma von Donin, Nicholas M, Pantuck, Allan, Klöpfer, Pia, Bevan, Paul, Fall, Barbara, Said, Jonathan, Belldegrun, Arie S, Chamie, Karim

Volltext

Phase 1 and 2 Randomized Clinical Studies Determine Lack of Efficacy for Anti-IL-17C Antibody MOR106 in Moderate-Severe Atopic Dermatitis von Thaçi, Diamant, Singh, Dave, Lee, Mark, Timmis, Helen, Jacobs, Dominique, Passier, Paul, Rohrer, Susanne, Beetens, Johan, Phung, De, Sondag, Eric, Babic, Goran, Würth, Guido, Kloepfer, Pia, Härtle, Stefan, Hüttner, Silke

Volltext

MOR202 alone and in combination with pomalidomide or lenalidomide in relapsed or refractory multiple myeloma: Data from clinically relevant cohorts from a phase I/IIa study von Raab, Marc S., Chatterjee, Manik, Goldschmidt, Hartmut, Agis, Hermine, Blau, Igor W, Einsele, Hermann, Engelhardt, Monika Martha, Ferstl, Barbara, Gramatzki, Martin, Röllig, Christoph, Weisel, Katja, Kloepfer, Pia, Weinelt, Dominika, Endell, Jan, Boxhammer, Rainer, Peschel, Christian

Volltext

The role of obesity in the incidence of lymphatic spread, disease-free, and overall survival: Data from the ARISER clinical trial von Chamie, Karim, Kloepfer, Pia, Fall, Barbara, Said, Jonathan W., Störkel, Stephan, Bevan, Paul, Belldegrun, Arie S., Pantuck, Allan J.

Volltext

ARISER: A randomized double blind phase III study to evaluate adjuvant cG250 treatment versus placebo in patients with high-risk ccRCC—Results and implications for adjuvant clinica... von Belldegrun, Arie S., Chamie, Karim, Kloepfer, Pia, Fall, Barbara, Bevan, Paul, Störkel, Stephan, Wilhelm, Olaf, Pantuck, Allan J.

Volltext

A phase I/IIa study of the human anti-CD38 antibody MOR202 (MOR03087) in relapsed or refractory multiple myeloma (rrMM) von Raab, Marc S., Goldschmidt, Hartmut, Agis, Hermine, Blau, Igor, Einsele, Hermann, Engelhardt, Monika Martha, Ferstl, Barbara, Gramatzki, Martin, Röllig, Christoph, Weisel, Katja, Kloepfer, Pia, Weinelt, Dominika, Härtle, Stefan, Peschel, Christian

Volltext